Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1350.20
11.70
(0.87%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy’s shines on receiving EIR from USFDA for Srikakulam Plant
>>
Dr. Reddy’s receives EIR from USFDA for Srikakulam Plant
>>
USFDA completes audit at Dr. Reddy’s CPS facility in Telangana
>>
Dr. Reddy’s shines on receiving EIR from USFDA for Srikakulam Plant
>>
Dr. Reddy’s receives EIR from USFDA for Srikakulam Plant
>>
Dr. Reddys Laboratories informs about company updates
>>
USFDA completes audit at Dr. Reddy’s API Mirfield plant in UK
>>
Dr. Reddy’s advances with arm planning to initiate Phase 2 trial of CA-170
>>
Dr. Reddy’s arm planning to initiate Phase 2 trial of CA-170
>>
German Regulatory issues zero critical, six major observations to Dr Reddy’s Duvvada facility
<<
<
85
86
87
...145
>
>>